Chemical Structure (Optison 01)
Optison Injection, Solution
Product Images NDC 0407-2707
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Optison (NDC 0407-2707). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ge Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (3 mL Vial Carton Label)
This is a description of a medical product called OPTISON, distributed by GE Healthcare, Inc. Each vial contains 3mL of an injectable suspension of microspheres that contain perflutren protein-type A, 10 mg of human USP albumin, N-acetyitryptophan, and caprylc acid in 0.9% aqueous sodium chloride with perflutren gas. The product is used for intravenous use in single-patient use vials, to be discarded after use. The storage temperature range is between 2° to 8°C (36" to 46°F), and it should not be frozen. The product is manufactured by GE Healthcare AS, located in Norway, and it is distributed in the USA. The recommended dosage, preparation, and administration are available on the prescribing information.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
